Case discussion
01Clinical context
An older patient with newly diagnosed rectal cancer referred for local staging with contrast-enhanced pelvic MRI to define tumour extent and nodal disease.
02Key imaging findings
Circumferential asymmetric mural thickening centred at the rectosigmoid junction, roughly 8.5–9.0 cm above the anal verge, spanning about 4.2 cm craniocaudally with maximal wall thickness of 17.8 mm. The lesion is T1-hypointense, T2-hyperintense with intense post-contrast enhancement. Ill-defined stranding and spiculation along the left lateral wall extend into mesorectal fat, suspicious for early transmural extension, but the tumour remains 17–18 mm from the left mesorectal fascia. Nodes are described in mesorectal and superior rectal stations, and also in obturator, external iliac and inguinal stations; these carry different staging implications and each requires assessment on its own morphology rather than size alone.
03Diagnostic reasoning
The tumour was localised on high-resolution T2 to the rectosigmoid junction opposite S2–S4, with T1-hypointensity, T2-hyperintensity and avid enhancement. Depth of invasion was assessed on T2: spiculated stranding extending into mesorectal fat raised the question of extramural extension rather than disease confined to the wall. The critical step was measuring the tumour-to-mesorectal-fascia distance (17–18 mm on the left), which keeps the circumferential resection margin potentially clear. Nodes were then catalogued by station and size, with the 11.6 × 9.4 mm superior rectal node and the pelvic sidewall nodes exceeding size criteria flagged as suspicious. The report explicitly defers final staging to histopathology and MDT review.
04Questions for clinical practice
Is the circumferential resection margin threatened? Not on this study — the tumour lies 17–18 mm from the left mesorectal fascia, well clear of the ~1 mm threshold that defines margin involvement, though the nearest suspicious nodes sit only 2–3 mm from the fascia and warrant attention. What is the imaging stage? The report describes at least T3. Nodal category is not settled here: the involved stations differ in staging weight and size alone does not establish metastasis; final staging requires histopathological correlation. What are the next steps? MDT discussion, biopsy confirmation, and PET-CT to exclude distant disease given the burden of suspicious nodes; post-neoadjuvant re-imaging is recommended to reassess response and surgical options.
05Teaching point
In rectal MRI staging the single most surgically relevant measurement is the distance from tumour (or suspicious node) to the mesorectal fascia — the plane of total mesorectal excision. The mesorectal fascia is the anatomical landmark on MRI; the circumferential resection margin is the surgical margin, and the two are not interchangeable. A reported distance contributes to that assessment alongside extramural depth, nodal distribution and EMVI status — it does not by itself decide between upfront surgery and neoadjuvant therapy. High-resolution T2 in the correct oblique plane, not enhancement, defines the relationship.
Shown for education. De-identified — no identifiable patient data. A radiology report is a specialist opinion and must be read with the full clinical context by the treating physician.